THERAPIXEL

Therapixel is a French software company founded in 2013 specializing in artificial intelligence for medical imaging, with offices in Nice and Paris. The company develops FDA-cleared and CE-marked AI-powered decision support software for breast cancer screening and digital mammography analysis. Its flagship product, MammoScreen®, features advanced deep learning algorithms and the MammoScreen Score™ tool to assist radiologists in interpreting screening mammograms, supporting both 2D and 3D imaging. MammoScreen integrates prior exam data to enhance malignancy prediction accuracy while reducing false positives. The company has established strategic partnerships with major healthcare networks including Mayo Clinic, Nuance Precision Imaging, and RamSoft's PACS platform to expand access to its technology across healthcare settings. Therapixel won the DREAM Digital Mammography Challenge in 2017 and conducts prospective clinical studies to validate AI utility in breast cancer screening programs.